169 related articles for article (PubMed ID: 29183632)
1. Recommendations for perioperative management of new pharmacological antifibrotic therapy in idiopathic pulmonary fibrosis.
González Larrocha O; Romero Rojano P; Ortega Mera U; Arízaga Maguregui A
Rev Esp Anestesiol Reanim (Engl Ed); 2018 Mar; 65(3):178-179. PubMed ID: 29183632
[No Abstract] [Full Text] [Related]
2. Forced vital capacity in idiopathic pulmonary fibrosis--FDA review of pirfenidone and nintedanib.
Karimi-Shah BA; Chowdhury BA
N Engl J Med; 2015 Mar; 372(13):1189-91. PubMed ID: 25806913
[No Abstract] [Full Text] [Related]
3. Two therapies now available for idiopathic pulmonary fibrosis.
Morrow T
Manag Care; 2014 Dec; 23(12):47-8. PubMed ID: 25939185
[No Abstract] [Full Text] [Related]
4. [Antifibrotic treatment].
von der Beck D; Löh B; Drakopanagiotakis F; Markart P; Günther A
Dtsch Med Wochenschr; 2014 Dec; 139(49):2523-5. PubMed ID: 25423462
[No Abstract] [Full Text] [Related]
5. Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions.
Raghu G; Selman M
Am J Respir Crit Care Med; 2015 Feb; 191(3):252-4. PubMed ID: 25635489
[No Abstract] [Full Text] [Related]
6. Hot off the breath: A big step forward for idiopathic pulmonary fibrosis.
Ryerson CJ; Collard HR
Thorax; 2014 Sep; 69(9):791-2. PubMed ID: 24996636
[No Abstract] [Full Text] [Related]
7. Novel treatments for idiopathic pulmonary fibrosis.
Spagnolo P
Am J Med; 2015 May; 128(5):447-9. PubMed ID: 25613299
[No Abstract] [Full Text] [Related]
8. New guideline on treatment of idiopathic pulmonary fibrosis.
Spagnolo P; Bonella F; Maher TM
Lancet Respir Med; 2015 Sep; 3(9):e31-e32. PubMed ID: 26380887
[No Abstract] [Full Text] [Related]
9. Update in Interstitial Lung Disease 2014.
Belloli EA; Martinez FJ; Flaherty KR
Am J Respir Crit Care Med; 2015 Sep; 192(5):538-43. PubMed ID: 26561676
[No Abstract] [Full Text] [Related]
10. New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses.
Ahluwalia N; Shea BS; Tager AM
Am J Respir Crit Care Med; 2014 Oct; 190(8):867-78. PubMed ID: 25090037
[TBL] [Abstract][Full Text] [Related]
11. Evaluating new treatment options.
Nathan SD
Am J Manag Care; 2017 Jul; 23(11 Suppl):S183-S190. PubMed ID: 28978213
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic pulmonary fibrosis: the turning point is now!
Funke M; Geiser T
Swiss Med Wkly; 2015; 145():w14139. PubMed ID: 26024356
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic advances in idiopathic pulmonary fibrosis.
George G; Vaid U; Summer R
Clin Pharmacol Ther; 2016 Jan; 99(1):30-2. PubMed ID: 26502087
[No Abstract] [Full Text] [Related]
14. Clinical trial research in focus: why do so many clinical trials fail in IPF?
Spagnolo P; Maher TM
Lancet Respir Med; 2017 May; 5(5):372-374. PubMed ID: 28412184
[No Abstract] [Full Text] [Related]
15. 3D pulmospheres serve as a personalized and predictive multicellular model for assessment of antifibrotic drugs.
Surolia R; Li FJ; Wang Z; Li H; Liu G; Zhou Y; Luckhardt T; Bae S; Liu RM; Rangarajan S; de Andrade J; Thannickal VJ; Antony VB
JCI Insight; 2017 Jan; 2(2):e91377. PubMed ID: 28138565
[TBL] [Abstract][Full Text] [Related]
16. Administration of nintedanib after discontinuation for acute exacerbation of idiopathic pulmonary fibrosis: a case report.
Ikeda S; Sekine A; Baba T; Yamakawa H; Morita M; Kitamura H; Ogura T
BMC Pulm Med; 2016 Mar; 16():38. PubMed ID: 26940352
[TBL] [Abstract][Full Text] [Related]
17. Current approaches to the management of idiopathic pulmonary fibrosis.
Raghu G; Richeldi L
Respir Med; 2017 Aug; 129():24-30. PubMed ID: 28732832
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic targets in idiopathic pulmonary fibrosis.
Kolb M; Bonella F; Wollin L
Respir Med; 2017 Oct; 131():49-57. PubMed ID: 28947042
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacological properties and clinical effects of the antifibrotic agent pirfenidone (Pirespa) for treatment of idiopathic pulmonary fibrosis].
Tokura T; Oku H; Tsukamoto Y
Nihon Yakurigaku Zasshi; 2009 Aug; 134(2):97-104. PubMed ID: 19672005
[No Abstract] [Full Text] [Related]
20. Pirfenidone treatment of idiopathic pulmonary fibrosis.
Azuma A
Ther Adv Respir Dis; 2012 Apr; 6(2):107-14. PubMed ID: 22333982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]